1. Home
  2. Browse
  3. Interactions
  4. Infectious Diseases

Infectious Diseases

211 - 225 of 248 Results
Sort Results:
Article: stronger warnings from Health Canada about movement disorders with metoclopramide September 2011
Article: two new protease inhibitors for chronic hepatitis C, Incivek (telaprevir) and Victrelis (boceprevir) September 2011
Commentary: Metoclopramide: Stronger Warnings on Risk of Abnormal Muscle Movements September 2011
Commentary: QT Prolongation, Torsades de Pointes, & Medication Safety September 2011
Commentary: New Restrictions, Contraindications, and Dose Limitations for Zocor (Simvastatin) September 2011
Article: limiting doses of simvastatin (Zocor, etc) July 2011
Article: Gilenya (je-LEN-yah, fingolimod) is the first ORAL drug to reduce relapses in relapsing-remitting multiple sclerosis (MS) April 2011
Article: warn about a possibly serious interaction between calcium channel blockers and macrolide antibiotics March 2011
Article: methicillin-resistant Staph aureus (MRSA) infections in hospitalized patients March 2011
Chart: Drug Therapy for Methicillin-Resistant Staph Aureus (MRSA) March 2011
Article: more cautious use of trimethoprim/sulfamethoxazole (TMP/SMX) in combo with drugs that increase potassium September 2010
Article: alerts for interactions between salmeterol and strong CYP3A4 inhibitors...clarithromycin, itraconazole, ritonavir, etc July 2010
Article: warnings about interactions between oxycodone and CYP3A4 drugs June 2010
Article: QT prolongation drug interaction alerts May 2010
Commentary: Increased Risk of Muscle Injury with High-Dose Zocor (Simvastatin) April 2010